71 related articles for article (PubMed ID: 38688611)
1. Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft.
Choijamts B; Naganuma Y; Nakajima K; Kawarabayashi T; Miyamoto S; Tachibana K; Emoto M
Cancer Sci; 2011 Feb; 102(2):452-9. PubMed ID: 21205068
[TBL] [Abstract][Full Text] [Related]
2. Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.
Wong CK; Lambert AW; Ozturk S; Papageorgis P; Lopez D; Shen N; Sen Z; Abdolmaleky HM; Győrffy B; Feng H; Thiagalingam S
Mol Cancer Res; 2020 Mar; 18(3):414-423. PubMed ID: 31932471
[TBL] [Abstract][Full Text] [Related]
3. Combination of Selenite and Butyrate Enhances Efficacy Against Colon Cancer by Targeting ASCT2-Mediated Amino Acid Metabolism.
Cui J; Li J; Zhao S; Fan L; Yin S; Zhao C; Hu H
Biol Trace Elem Res; 2024 Aug; 202(8):3565-3573. PubMed ID: 37897593
[TBL] [Abstract][Full Text] [Related]
4. A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells.
Takahashi T; Morotomi M; Nomoto K
Cancer Sci; 2004 Jun; 95(6):514-9. PubMed ID: 15182433
[TBL] [Abstract][Full Text] [Related]
5. The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.
Greene J; Nguyen A; Bagby SM; Jones GN; Tai WM; Quackenbush KS; Schreiber A; Messersmith WA; Devaraj KM; Blatchford P; Eckhardt SG; Cadogan EB; Hughes GD; Smith A; Pitts TM; Arcaroli JJ
Oncotarget; 2017 Dec; 8(67):110904-110913. PubMed ID: 29340025
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.
Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Murakami T; Unno M; Hoffman RM
Cells; 2019 May; 8(5):. PubMed ID: 31052611
[TBL] [Abstract][Full Text] [Related]
7. Innovative Nanoparticulate Strategies in Colon Cancer Treatment: A Paradigm Shift.
Yadav R; Bhawale R; Srivastava V; Pardhi E; Bhalerao HA; Sonti R; Mehra NK
AAPS PharmSciTech; 2024 Mar; 25(3):52. PubMed ID: 38429601
[TBL] [Abstract][Full Text] [Related]
8. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
Sato M; Mizuta K; Han Q; Morinaga S; Kang BM; Kubota Y; Mori R; Baranov A; Kobayashi K; Ardjmand D; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
In Vivo; 2024; 38(3):1058-1063. PubMed ID: 38688611
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis.
Kim MJ; Han Q; Bouvet M; Hoffman RM; Park JH
Anticancer Res; 2023 Jan; 43(1):19-24. PubMed ID: 36585181
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet.
Sato M; Han Q; Mori R; Mizuta K; Kang BM; Morinaga S; Kobayashi N; Ichikawa Y; Nakajima A; Hoffman RM
Anticancer Res; 2024 Apr; 44(4):1499-1504. PubMed ID: 38538002
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer.
Sato M; Han Q; Kubota Y; Baranov A; Ardjmand D; Mizuta K; Morinaga S; Kang BM; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
Anticancer Res; 2024 Jan; 44(1):31-35. PubMed ID: 38159986
[TBL] [Abstract][Full Text] [Related]
14. [
Kubota Y; Sato T; Han Q; Hozumi C; Morinaga S; Mizuta K; Tsunoda T; Hoffman RM
In Vivo; 2024; 38(1):253-258. PubMed ID: 38148095
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
